Publications (922)
-
Special Report: Prenatal Screening Policies in Europe 2010
Special Report: Prenatal Screening Policies in Europe 2010
EUROCAT
EUROCAT Central Registry, University of Ulster, 2010
Subjects: Prenatal Screening & Diagnosis -
Subtelomeric deletion of 12p: description of a third case and review
Subtelomeric deletion of 12p: description of a third case and review
MacDonald AH, Rodriguez L, Acena MI, Martinez-Frias M-L, Sanchez-Izquierdo D, Zuazo E, Martinez-Fernandez ML
American Journal of Medical Genetics Part A, 2010 , 152A: 1561 - 1566
Subjects: Genetics and Syndromes
Anomalies: Chromosomal (other than Down Syndrome) -
Surveillance of adverse fetal effects of medications (SAFE-med): findings from the International Clearinghouse of Birth Defects Surveillance and Research
Surveillance of adverse fetal effects of medications (SAFE-med): findings from the International Clearinghouse of Birth Defects Surveillance and Research
Lisi A, Botto L, Robert-Gnansia E, Castilla E, Bakker M, Bianca S, Cocchi G, de Vigan C, Dutra Mda G, Horacek J, Merlob P, Pierini A, Scarano G, Sipek A
Reproductive Toxicology, 2010 , 29: (4) 433 - 442
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
Teratogenic potential of pholedrine: a sympathomimetic vasoconstrictive drug - a population-based case-control study
Teratogenic potential of pholedrine: a sympathomimetic vasoconstrictive drug - a population-based case-control study
Banhidy F, Acs N, Puho EH, Czeizel AE
Congenital Anomalies, 2010 , 50: 122 - 128
Subjects: Medication During Pregnancy -
Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European Register-based study
Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European Register-based study
Garne E, Khoshnood B, Loane M, Boyd P, Dolk H
British Journal of Gynaecology, 2010 , 117: (6) 660 - 666
Subjects: Prenatal Screening & Diagnosis -
The efficacy of antihypertensive treatment in pregnant women with chronic and gestational hypertension: a population-based study
The efficacy of antihypertensive treatment in pregnant women with chronic and gestational hypertension: a population-based study
Banhidy F, Acs N, Puho EH, Czeizel AE
Hypertension Research, 2010 , 33: (5) 460 - 466
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
The prevalence of congenital anomalies in Europe
The prevalence of congenital anomalies in Europe
Dolk H, Loane M, Garne E
Advances in Experimental Medicine & Biology, 2010 , 686: 349 - 364
Subjects: Prevalence & Perinatal Mortality -
Treatment of hyperthyroidism in pregnancy and birth defects
Treatment of hyperthyroidism in pregnancy and birth defects
Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto L, Mastroiacovo P, SAFE-Med Study Group
Journal of Clinical Endocrinology and Metabolism, 2010 , 95: (11) E337 - E341
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
Valproic acid monotherapy in pregnancy and major congenital malformations
Valproic acid monotherapy in pregnancy and major congenital malformations
Jentink J, Loane M, Dolk H, Barisic I, Garne E, Morris J, de Jong-van den Berg L and EUROCAT Antiepileptic Study Working Group
The New England Journal of Medicine, 2010 , 362: (23) 2185 - 2193
Subjects: Medication During Pregnancy, Prevention & Risk Factors -
Valproic acid use in pregnancy and congenital malformations (Reply letter Vajda/O'Brien)
Valproic acid use in pregnancy and congenital malformations (Reply letter Vajda/O'Brien)
Jentink J, Loane M, Dolk H, Barisic I, Garne E, Morris J, de Jong-van den Berg L
The New England Journal of Medicine, 2010 , 363: (18) 1771 - 1772
Subjects: Medication During Pregnancy, Prevention & Risk Factors